CANNAPHARMARX, INC. Deferred Federal, State and Local, Tax Expense (Benefit)
CANNAPHARMARX, INC. (CPMD) reported Deferred Federal, State and Local, Tax Expense (Benefit) of $1.54 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2026-03-31
- CANNAPHARMARX, INC. deferred federal, state and local, tax expense (benefit) for fiscal 2025 was $1.54M, a 10.22% increase from fiscal 2024.
- CANNAPHARMARX, INC. deferred federal, state and local, tax expense (benefit) for fiscal 2024 was $1.40M.
- CANNAPHARMARX, INC. deferred federal, state and local, tax expense (benefit) for fiscal 2023 was -$1.85M.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $1.54M 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.40M 10-K · filed 2026-03-31 |
| 2023-12-31 | -$1.85M 10-K · filed 2025-04-10 |